Skip navigation

Zastosuj identyfikator do podlinkowania lub zacytowania tej pozycji: http://hdl.handle.net/20.500.12128/13624
Pełny rekord metadanych
DC poleWartośćJęzyk
dc.contributor.authorKnapik-Kowalczuk, Justyna-
dc.contributor.authorKramarczyk, Daniel-
dc.contributor.authorChmiel, Krzysztof-
dc.contributor.authorRomanova, Jana-
dc.contributor.authorKawakami, Kohsaku-
dc.contributor.authorPaluch, Marian-
dc.date.accessioned2020-04-23T10:25:42Z-
dc.date.available2020-04-23T10:25:42Z-
dc.date.issued2020-
dc.identifier.citation"Pharmaceutics" Vol. 12, iss. 4 (2020), art. no 384pl_PL
dc.identifier.issn1999-4923-
dc.identifier.urihttp://hdl.handle.net/20.500.12128/13624-
dc.description.abstractIn this paper, the role of mesoporous silica (MS) particle size in the stabilization of amorphous simvastatin (SVT) is revealed. For inhibiting recrystallization of the supercooled drug, the two MS materials (Syloid® XDP 3050 and Syloid® 244 FP) were employed. The crystallization tendency of SVT alone and in mixture with the MS materials was investigated by Differential Scanning Calorimetry (DSC) and Broadband Dielectric Spectroscopy (BDS). Neither confinement of the SVT molecules inside the MS pores nor molecular interactions between functional groups of the SVT molecules and the surface of the stabilizing excipient could explain the observed stabilization effect. The stabilization effect might be correlated with diffusion length of the SVT molecules in the MS materials that depended on the particle size. Moreover, MS materials possessing different particle sizes could offer free spaces with different sizes, which might influence crystal growth of SVT. All of these factors must be considered when mesoporous materials are used for stabilizing pharmaceutical glasses.pl_PL
dc.language.isoenpl_PL
dc.rightsUznanie autorstwa 3.0 Polska*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/pl/*
dc.subjectSimvastatinpl_PL
dc.subjectamorphous pharmaceuticalspl_PL
dc.subjectmesoporous silicapl_PL
dc.subjectstabilizationpl_PL
dc.subjectrecrystallizationpl_PL
dc.titleImportance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals - The Case of Simvastatinpl_PL
dc.typeinfo:eu-repo/semantics/articlepl_PL
dc.identifier.doi10.3390/pharmaceutics12040384-
Pojawia się w kolekcji:Artykuły (WNŚiT)

Pliki tej pozycji:
Plik Opis RozmiarFormat 
Knapik-Kowalczuk_Importance_of_mesoporous_silica_particle_size_in_the_stabilization.pdf2,46 MBAdobe PDFPrzejrzyj / Otwórz
Pokaż prosty rekord


Uznanie Autorstwa 3.0 Polska Creative Commons Creative Commons